Michelle A. Ojemuyiwa
Expertise in
13
conditions

Dr. Michelle A. Ojemuyiwa

Oncology | Hematology
100 Market Place Boulevard, Suite 200, 
Cartersville, GA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
13
conditions
100 Market Place Boulevard, Suite 200, 
Cartersville, GA 

Overview

Michelle Ojemuyiwa is an Oncologist and a Hematologist practicing medicine in Cartersville, Georgia.

Dr. Ojemuyiwa is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Ojemuyiwa is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 2 clinical trials. Dr. Ojemuyiwa is currently accepting new patients.

Graduate Institution

Uniform Services University Of Health Sciences, Medicine, 2018

Specialties

Oncology
Hematology

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine - Hematology
American Board Of Internal Medicine - Medical Oncology
American Board Of Internal Medicine

Fellowships

National Capital Consortium, WRNMMC, 2014

Hospital Affiliations

Wellstar Paulding Medical Center
Wellstar Cobb Medical Center
Piedmont Cartersville Medical Center
Wellstar Kennestone Regional Medical Center
Wellstar North Fulton Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Northwest Georgia Oncology Centers
100 Market Place Boulevard, Suite 200, Cartersville, GA 30121

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: September 04, 2026
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients With Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum-Based Therapy
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients With Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum-Based Therapy
Enrollment Status: Completed
Publish Date: August 21, 2023
Intervention Type: Drug
Study Drugs: Ramucirumab, Docetaxel
Study Phase: Phase 3
View 1 Less Clinical Trial

4 Total Publications

Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.
Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.
Journal: Clinical case reports
Published: May 08, 2018
Similar Doctors
Expertise in
5
conditions
Dr. Carlton D. Dampier
Hematology | Oncology
Expertise in
5
conditions
Dr. Carlton D. Dampier
Hematology | Oncology
Referral may be required

Children's Healthcare Of Atlanta At Hughes Spalding

35 Jesse Hill Jr Dr SE, 
Atlanta, GA 
 (38.9 miles away)
404-785-9800
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Carlton Dampier is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Dampier is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Dampier is currently accepting new patients.

Expertise in
9
conditions
Dr. Lakshmanan Krishnamurti
Hematology | Oncology
Expertise in
9
conditions
Dr. Lakshmanan Krishnamurti
Hematology | Oncology
Referral may be required

Egleston Children's Hospital At Emory

1405 Clifton Rd NE, 
Atlanta, GA 
 (39.0 miles away)
404-785-1112
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lakshmanan Krishnamurti is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Krishnamurti is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Krishnamurti is currently accepting new patients.

Expertise in
15
conditions
Dr. Satheesh M. Chonat
Hematology | Oncology
Expertise in
15
conditions
Dr. Satheesh M. Chonat
Hematology | Oncology
Referral may be required

Arthur M. Blank Hospital

2220 N Druid Hills Rd NE, 
Atlanta, GA 
 (37.3 miles away)
404-785-1200
Languages Spoken:
English, Hindi, Kannada, Malayalam, Spanish, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Satheesh Chonat is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Chonat is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Hemolytic Anemia, Anemia, Hemolysis, Congenital Hemolytic Anemia, and Splenectomy. Dr. Chonat is currently accepting new patients.

Frequently Asked Questions about Dr. Michelle A. Ojemuyiwa

How do I make an appointment with Dr. Michelle A. Ojemuyiwa?

You can book an appointment with Dr. Michelle A. Ojemuyiwa by calling their office at 770-386-7253. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michelle A. Ojemuyiwa a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michelle A. Ojemuyiwa is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michelle A. Ojemuyiwa specialize in?

While Dr. Michelle A. Ojemuyiwa is a Oncology, they have specific expertise in Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Michelle A. Ojemuyiwa participate in research or clinical trials?

Yes. Dr. Michelle A. Ojemuyiwa has published 4 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Michelle A. Ojemuyiwa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michelle A. Ojemuyiwa accept my insurance?

Dr. Michelle A. Ojemuyiwa accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 770-386-7253 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ojemuyiwa's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 103 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile